Lisa Rosenbaum.

Second, letting the marketplace shape usability assumes that clinicians are the target users. Therefore EHRs will be only as good as the quality metrics they’re designed to catch; technology can’t get over fundamental measurement issues. We measure many things that have no value to patients, while a lot of what individuals do worth, including our attention, remains unmeasurable. Why, Wachter asks, do we do nothing similar in health care? In a moving passage, Wachter speaks with a renowned surgeon who once spent his evenings before surgery reading his notes on the next day’s patients. No longer. His notes have already been rendered homogeneous by the tyranny of clicks and auto-populated fields uselessly.The approach tries to overcome an enormous chicken-and-egg problem in medical research: Insufficient people volunteer for research of new treatments partly because researchers can’t promise the studies can help them – but without plenty of volunteers, researchers can’t research new treatment plans. But a fresh ‘adaptive’ method of designing medical studies could help. In a recent paper in the Journal of the American Medical Association, and in a number of clinical trials today being planned at the University of Michigan Health partner and System establishments, adaptive design has arrive to the fore. Professionals from U-M and other major medical centers state that the approach makes the most sense in situations where time is normally of the essence – such as emergency treatment – or where in fact the medical stakes are high and there are few great treatment options – such as some types of cancer.